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GILT Modulates CD4þ T-Cell Tolerance
to the Melanocyte Differentiation Antigen
Tyrosinase-Related Protein 1
Matthew P. Rausch1,2 and K. Taraszka Hastings1,2,3
Gamma-IFN-inducible lysosomal thiol reductase (GILT) facilitates major histocompatibility complex class
II-restricted processing through endocytic reduction of protein disulfide bonds and is necessary for efficient
class II-restricted processing of melanocyte differentiation antigen, tyrosinase-related protein 1 (TRP1). Using
class II-restricted, TRP1-specific T-cell receptor transgenic mice, we identify a role, to our knowledge, previously
unreported, for GILT in the maintenance of tolerance to TRP1. TRP1-specific thymocytes are centrally deleted in
the presence of GILT and TRP1. In contrast, CD4 single-positive thymocytes and peripheral T cells develop in the
absence of GILTor TRP1, demonstrating that GILT is required for negative selection of TRP1-specific thymocytes.
Although TRP1-specific T cells escape thymic deletion in the absence of GILT, they are tolerant to TRP1 and do
not induce vilitigo. TRP1-specific T cells that develop in the absence of GILT have diminished IL-2 and IFN-g
production. Furthermore, GILT-deficient mice have a 4-fold increase in the percentage of TRP1-specific
regulatory T (Treg) cells compared with TRP1-deficient mice, and depletion of Treg cells partially restores the
ability of GILT-deficient TRP1-specific CD4þ T cells to induce vitiligo. Thus, GILT has a critical role in regulating
CD4þ T-cell tolerance to an endogenous skin-restricted antigen relevant to controlling autoimmunity and
generating effective immunotherapy for melanoma.
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INTRODUCTION
Major histocompatibility complex (MHC) class II-restricted
antigen (Ag) presentation has an essential role in the
development of the CD4þ T-cell repertoire (Klein et al.,
2009). Cortical thymic epithelial cells present self-peptide/
MHC complexes to CD4þCD8þ double-positive thymocytes
(Nikolic-Zugic and Bevan, 1990; Hogquist et al., 1994; Lo
et al., 2009). Ligation of specific TCRs with their cognate self-
peptide/MHC complexes provides double-positive thymo-
cytes with survival signals termed positive selection and lead
to downregulation of the unused coreceptor. CD4þ thymo-
cytes interact with dendritic cells (DCs) and medullary thymic
epithelial cells (mTECs) presenting self-peptide/MHC com-
plexes. Thymocytes that bind self-peptide/MHC complexes
with high avidity die by apoptosis (negative selection;
Kisielow et al., 1988; Swat et al., 1991; McCaughtry et al.,
2008). Autoreactive T cells that escape negative selection
may differentiate into regulatory T (Treg) cells or be con-
trolled by peripheral tolerance mechanisms (Jordan et al.,
2001; Apostolou et al., 2002; Fontenot et al., 2003). Thus,
factors that influence the generation of MHC class
II-restricted peptides have the potential to shape CD4þ
T-cell tolerance to self-Ags.
MHC class II-restricted epitopes are generated in the
endocytic pathway by disulfide bond reduction and proteo-
lytic degradation of endogenous and exogenous proteins in
this compartment (Bryant and Ploegh, 2004). Gamma-IFN-
inducible lysosomal thiol reductase (GILT) is the only
reductase known to be localized to the class II loading
compartment (Luster et al., 1988; Arunachalam et al., 2000;
Maric et al., 2001). GILT facilitates the processing and
presentation of certain class II epitopes through reduction of
protein disulfide bonds (Maric et al., 2001; Hastings et al.,
2006; Sealy et al., 2008). Melanocyte differentiation Ags,
including tyrosinase, tyrosinase-related protein (TRP) 1 (gp75),
TRP2, and gp100, are melanosomal integral membrane
proteins involved in melanin synthesis and melanosome
structure. These Ags are clinically relevant for both the
autoimmune destruction of melanocytes, which results in
vitiligo, and antimelanoma immune responses. Antibodies
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(Naughton et al., 1983) and CD8þ T cells (Ogg et al., 1998;
Lang et al., 2001; Palermo et al., 2001; Mandelcorn-Monson
et al., 2003; van Geel et al., 2010) specific for melanocyte
differentiation Ags have been identified in vitiligo patients,
and CD4þ and CD8þ T cells from melanoma patients
recognize multiple epitopes from melanocyte differentia-
tion Ags (http://www.cancerimmunity.org/peptidedatabase/
differentiation.htm). GILT is required for efficient MHC class
II-restricted Ag processing of tyrosinase and TRP1 (Haque
et al., 2002; Rausch et al., 2010). As this group of Ags is
presented by MHC class II (Topalian et al., 1996; Kobayashi
et al., 1998; Overwijk et al., 1999; Wang et al., 1999;
Touloukian et al., 2000, 2002; Robbins et al., 2002; Parkhurst
et al., 2004; Muranski et al., 2008) and contains disulfide
bonds (Negroiu et al., 2000; Berson et al., 2001; Garcia-
Borron and Solano, 2002), GILT is likely to be important in
enhancing class II-restricted processing of multiple epitopes
from this clinically relevant group of skin-restricted Ags.
To evaluate the role of GILT in the development of CD4þ
T-cell responses to melanocyte differentiation Ags, we use a
class II-restricted TRP1-specific TCR transgenic (Tg) mouse
strain (Muranski et al., 2008). RAG-expressing Tg mice
spontaneously develop vitiligo (Rausch et al., 2010; Xie
et al., 2010). In the absence of GILT, RAG-expressing Tg mice
have a significant delay in vitiligo onset due to impaired class
II-restricted processing of TRP1 and diminished T-cell
activation (Rausch et al., 2010). Paradoxically, we found an
increased percentage of TRP1-specific T cells in the thymus
and peripheral lymphoid organs of GILT-deficient, RAG-
expressing Tg mice (Rausch et al., 2010), suggesting that GILT
may have a role in T-cell development and tolerance. Here,
we demonstrate that GILT functions to regulate tolerance of
CD4þ TRP1-specific T cells. GILT is required for negative
selection of TRP1-specific thymocytes. Peripheral TRP1-
specific CD4þ T cells that develop in the absence of GILT
are tolerant to TRP1 in that they are unable to induce vitiligo
and do not produce IL-2 and IFN-g after Ag exposure.
Tolerance of CD4þ TRP1-specific T cells from GILT-deficient
mice is partially mediated by increased Treg cells.
RESULTS
RAG-deficient TRP1-specific TCR Tg mice do not develop
spontaneous vitiligo
To restrict the analysis to T cells specific for TRP1, Tg and
GILT/ Tg mice were backcrossed onto the RAG/ back-
ground. All mouse strains in this study are on the RAG/
background unless otherwise stated. Surprisingly, neither
GILT-expressing Tg nor GILT/ Tg mice developed vitiligo
when followed up for over 1 year (data not shown). To better
understand the phenotype of these mice, the lymphoid organs
were evaluated. The white-based brown (TRP1Bw) mouse
strain contains a radiation-induced inversion interrupting the
gene encoding TRP1 (Smyth et al., 2006) and serves as an
Ag-negative control. No significant differences in total
thymocyte number were observed among AgGILTþ /þTg,
AgþGILT/Tg, and AgþGILTþ /þTg mice (Figure 1a). In
RAG-expressing Tg mice that develop vitiligo, CD4 single-
positive (CD4SP) thymocytes develop (Rausch et al., 2010).
In contrast, in RAG-deficient Tg mice, CD4SP thymocytes did
not readily develop indicating that TRP1-specific thymocytes
are negatively selected in the presence of Ag and GILT (Figure
1b, upper right). Endogenous TCRs, which are present in
RAG-expressing TRP1-specific Tg mice (Rausch et al., 2010),
likely rescue autoreactive T cells from thymic deletion, as in
other TCR Tg models (Zal et al., 1996).
GILT is required for negative selection of TRP1-specific
thymocytes
In comparison with AgþGILTþ /þTg mice, an increased
percentage of CD4SP thymocytes developed in AgþGILT/
Tg mice (Figure 1b, upper left), demonstrating that GILT is
required for central deletion of TRP1-specific thymocytes. In
the absence of TRP1, TRP1-specific thymocytes are positively
selected and CD4SP cells develop (Figure 1b, lower left).
Both AgþGILT/Tg and AgGILTþ /þTg mice had a
significant increase in the percentage of CD4SP thymocytes
compared with AgþGILTþ /þTg mice (Po0.05 and o0.01,
respectively; Figure 1c). No difference in the percentage of
CD4SP thymocytes was observed between AgþGILT/Tg
and AgGILTþ /þTg mice (Figure 1c), indicating that the
absence of GILT and absence of TRP1 have similar effects on
thymic selection. T cells can escape thymic deletion by
downregulation of coreceptors (Mamalaki et al., 1996).
However, there was no evidence of CD4 downregulation,
as no differences in the percentage of CD4CD8 double-
negative thymocytes were seen (Figure 1b). These data
indicate that GILT is required for negative selection of
TRP1-specific thymocytes.
Peripheral CD4þ TRP1-specific T cells develop in the absence
of GILT
Next, we examined the skin-draining lymph nodes for the
presence of CD4þ TRP1-specific T cells. No significant
differences in total lymph node cell numbers were observed;
the mean number of lymph node cells in AgGILTþ /þTg,
AgþGILT/Tg, and AgþGILTþ /þTg mice were 1.2
106±5.9105, 2.5 106±8.5105, and 1.3 106±2.9
105 cells, respectively. TRP1-specific T cells were identified
by expression of CD4 and TCR Vb14. Large percentages of
CD4þVb14þ T cells were present in the periphery of
AgGILTþ /þTg and AgþGILT/Tg mice, but not
AgþGILTþ /þTg mice (Figure 2a), consistent with the thymic
analyses (Figure 1). Both AgGILTþ /þTg and AgþGILT/Tg
mice had a significant increase in the percentage of
TRP1-specific T cells in lymph nodes compared with
AgþGILTþ /þTg mice (Po0.001; Figure 2b). In addition,
AgþGILT/Tg mice had a decreased percentage of
CD4þVb14þ cells (Po0.001; Figure 2b) and an increased
percentage of CD4Vb14þ cells (Figure 2a) compared with
AgGILTþ /þTg mice. Analysis of the CD4Vb14þ cells from
AgþGILT/Tg mice showed that 87% were CD3þ and the
remaining CD3 cells expressed the natural killer cell marker
CD49b (Figure 2c). Approximately 1/3 of the CD4Vb14þ
cells were CD8þ and 1/2 were CD4CD8 (Figure 2c),
suggesting that the TRP1-specific TCR may allow selection of
CD8þ and double-negative T cells. Next, as AgþGILT/Tg
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mice express TRP1 and can potentially present low levels of
TRP1 peptide/MHC class II complexes, we evaluated markers
of naive and activated T cells. As expected, TRP1-specific T
cells from Ag-deficient mice were naive (CD62LþCD44;
Figure 2d, left). In AgþGILT/Tg mice, the majority of TRP1-
specific cells were naive, and a small percentage of T cells
had an effector memory phenotype (CD62LCD44þ ; Figure
2d, right), suggesting that the level of TRP1 presentation in
GILT-deficient mice supports T-cell activation.
CD4þ TRP1-specific T cells from GILT/ mice do not induce
vitiligo
Previous studies have demonstrated that CD4þ T cells from
AgGILTþ /þTg mice induce severe vitiligo and have
antimelanoma activity (Muranski et al., 2008; Quezada
et al., 2010; Rausch et al., 2010; Xie et al., 2010). To
evaluate the function of T cells that develop in the absence of
GILT, we performed adoptive transfer of CD4þ T cells from
AgGILTþ /þTg and AgþGILT/Tg mice into RAG/
recipients. Adoptive transfer of CD4þ T cells from
AgGILTþ /þTg mice into RAG/ recipients produced large,
confluent patches of depigmented fur and ocular damage
with a median onset of 4 weeks (Figure 3a and b), consistent
with prior studies and expression of TRP1 in melanocytes
located in the hair follicles and eye. In contrast, adoptive
transfer of CD4þ T cells from AgþGILT/Tg mice did not
produce vitiligo after 15–22 weeks (Figure 3a and c). These
data show that although CD4þ TRP1-specific T cells escape
negative selection in the absence of GILT, they maintain
tolerance to TRP1 and are functionally distinct from those
that develop in the absence of Ag.
GILT-deficient TRP1-specific T cells have diminished cytokine
production following Ag exposure
To explore the functional differences between CD4þ TRP1-
specific T cells from AgGILTþ /þTg and AgþGILT/Tg
mice, IL-2 production was assessed in response to TRP1
stimulation in vitro. CD4þ T cells from AgGILTþ /þTg and
AgþGILT/Tg mice were cocultured with bone marrow-
derived DCs and TRP1 peptide (which does not require
intracellular processing), melanoma cell lysate (as a source of
TRP1 protein), or squamous cell carcinoma lysate (negative
control). CD4þ T cells from AgþGILT/Tg mice produced
markedly less IL-2 than those from AgGILTþ /þTg mice in
response to TRP1 peptide or TRP1 protein (Figure 4a). In
addition, anti-CD3 and anti-CD28 stimulation resulted in less
IL-2 production by CD4þ T cells from GILT-deficient mice
(Figure 4a).
Next, we measured cytokine production following
in vivo Ag exposure. CD4þ TRP1-specific T cells from
AgþGILT/Tg and AgGILTþ /þTg mice were adoptively
transferred into TRP1-expressing RAG/ hosts. Consistent
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Figure 1. GILT is required for negative selection of TRP1-specific thymocytes. (a) Total thymocyte numbers from AgGILTþ /þTg (n¼11), AgþGILT/Tg
(n¼ 10), and AgþGILTþ /þTg (n¼ 9) mice. Columns in a and c represent the mean±SE. Data are from three pooled experiments. (b) CD4 and CD8 staining
of thymocytes with dead-cell exclusion using 7-AAD from representative AgGILTþ /þTg, AgþGILT/Tg, AgþGILTþ /þTg, and wild-type mice. Numbers
represent percentage in gate. (c) Percentage of TRP1-specific CD4SP thymocytes in AgGILTþ /þTg, AgþGILT/Tg, and AgþGILTþ /þTg mice compared by
analysis of variance with the Bonferroni correction for multiple comparisons (*Po0.05; **Po0.01). Data are representative of three experiments with 3–4 mice per
group. Ag, antigen; CD4SP, CD4 single positive; GILT, gamma-IFN-inducible lysosomal thiol reductase; Tg, transgenic; TRP1, tyrosinase-related protein 1.
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with our in vitro data, a smaller percentage of CD4þ TRP1-
specific T cells from AgþGILT/Tg mice produced IL-2
compared with those from AgGILTþ /þTg mice (Figure 4b).
Given that T-cell-derived IFN-g is essential for the antimela-
noma activity of CD4þ T cells from AgGILTþ /þTg mice
(Quezada et al., 2010; Xie et al., 2010), we investigated IFN-
g production. Similarly, a decreased percentage of CD4þ
TRP1-specific T cells from AgþGILT/Tg mice produced
IFN-g following in vivo Ag exposure (Figure 4b). As IL-10
production by Treg cells can contribute to tolerance and the
absence of Treg cells accelerates vilitigo onset in RAG-
expressing TRP1-specific Tg mice (Xie et al., 2010), we
evaluated IL-10 production. Although a greater percentage of
CD4þ T cells from AgGILTþ /þTg mice produced IL-10
compared with those from AgþGILT/Tg mice in response
to in vivo TRP1 exposure, the percentage of CD4þ IL-10þ
cells in both strains was lower than the percentage of
cells expressing IL-2 or IFN-g (Figure 4b). As previous
studies have demonstrated that CD4þ TRP1-specific T cells
from AgGILTþ /þTg mice differentiated in vitro under Th17
polarizing conditions had superior antitumor activity
(Muranski et al., 2008), we assessed IL-17 production. Very
few TRP1-specific T cells from either strain produced IL-17
after in vivo TRP1 exposure (Figure 4b), suggesting that these
cells do not readily differentiate into Th17 cells in vivo.
Reduced IL-2 and IFN-g production by TRP1-specific T cells
from AgþGILT/Tg mice following in vitro and in vivo Ag
exposure is consistent with the inability of these cells
to induce vitiligo (Figure 3), and further demonstrates that
TRP1-specific T cells that develop in the absence of GILT are
tolerant.
Increased percentage of Treg cells in GILT-deficient mice
contributes to TRP1-specific CD4þ T-cell tolerance
As Treg cells have been shown to delay spontaneous vitiligo
in RAG-expressing TRP1-specific Tg mice and Treg cells
develop in RAG-deficient AgGILTþ /þTg mice (Xie et al.,
2010), we investigated whether GILT expression affected the
development of TRP1-specific Treg cells. Skin-draining
lymph nodes from AgþGILT/Tg mice had an B4-fold
increase in the percentage of CD4þVb14þCD25þFoxp3þ
Treg cells compared with AgGILTþ /þTg mice (Figure 5a
and b; Po0.001). However, no difference was observed in
the absolute number of TRP1-specific CD25þFoxp3þ Treg
cells between these strains (Figure 5c), given the decreased
percentage of CD4þVb14þ T cells in AgþGILT/Tg mice
(Figure 2b).
To determine whether the increased percentage of TRP1-
specific Treg cells observed in AgþGILT/Tg mice con-
tributes to TRP1 tolerance, CD4þCD25 or total CD4þ T
cells from AgþGILT/Tg mice were adoptively transferred
into RAG/ mice. Transfer of Treg cell-depleted CD4þ T
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Figure 2. Peripheral CD4þ TRP1-specific T cells develop in the absence of GILT. (a) Vb14 (b-chain in the TCR Tg) and CD4 staining of lymph node cells
with dead-cell exclusion using 7-AAD from representative AgGILTþ /þTg, AgþGILT/Tg, AgþGILTþ /þTg, and wild-type mice. Numbers indicate percentage
in quadrants in a, c, and d. (b) Percentage of CD4þVb14þ lymph node cells in AgGILTþ /þTg, AgþGILT/Tg, and AgþGILTþ /þTg mice compared by
analysis of variance with the Bonferroni correction for multiple comparisons (***Po0.001). Columns represent the mean±SE. Data represent three
pooled experiments with at least three mice per group in each. (c) CD3, CD8, and CD49b staining of CD4Vb14þ -gated cells from the lymph nodes of
AgþGILT/Tg mice. (d) CD62L and CD44 staining of CD4þVb14þ T cells from representative AgGILTþ /þTg and AgþGILT/Tg mice. Ag, antigen;
GILT, gamma-IFN-inducible lysosomal thiol reductase; Tg, transgenic; TRP1, tyrosinase-related protein 1.
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cells from AgþGILT/Tg mice induced mild vitiligo in all
recipient mice with a median onset of 9 weeks (Figure 6a).
Vitiligo induced by CD4þCD25 TRP1-specific T cells was
characterized by sparse individual white hairs, which
progressed to involve nearly the entire dorsum of the mice;
ocular damage was not observed (Figure 6b, left side). As in
Figure 3, transfer of sorted total CD4þ TRP1-specific T cells
from AgþGILT/Tg mice did not induce autoimmunity after
15 weeks (Figure 6b, right side). These data demonstrate that
Treg cell depletion partially restores the ability of CD4þ
TRP1-specific T cells that develop in the absence of GILT to
induce autoimmunity.
DISCUSSION
The TRP1-specific TCR Tg mouse strain (Muranski et al.,
2008) is an ideal model to investigate the development of
CD4þ T-cell-mediated immunity to a skin-restricted Ag
relevant to immunosurveillance of cutaneous malignancy
and the pathogenesis of autoimmunity. The Tg T cells are
specific for a naturally occurring epitope of a melanocyte
differentiation Ag. Another advantage is that T cells are
specific for a self-Ag expressed in its native genetic context
rather than a foreign Ag expressed under a tissue-specific
promoter that may not fully recapitulate thymic and tissue-
specific expression and development of tolerance.
Negative selection of TRP1-specific thymocytes in
AgþGILTþ /þTg mice, but not in AgþGILT/Tg mice,
demonstrates that GILT is required for central tolerance to
this skin-restricted Ag (Figure 1). Similar to GILT-facilitated
class II-restricted presentation of TRP1 in B cells and bone
marrow-derived DCs (Rausch et al., 2010), we hypothesize
that GILT improves the efficiency of TRP1 processing and
presentation by the thymic antigen presenting cells (APCs)
that mediate negative selection, namely thymic DCs and
mTECs. Our findings are consistent with prior studies
demonstrating diminished negative selection with reduced
or absent class II on thymic APCs or diminished self-Ag
expression. In OT-II Tg mice that express OVA, a lack of
MHC class II expression on thymic DCs results in diminished
negative selection of CD4þ OVA-specific T cells (Gallegos
and Bevan, 2004). Similarly, inhibition of MHC class II
expression on mTECs results in diminished negative selection
of autoreactive CD4þ T cells in several TCR Tg systems
(Hinterberger et al., 2010). Mice lacking expression of
autoimmune regulator (Aire), a transcription factor that
controls the expression of a large number of tissue-restricted
self-Ags in the thymus (Anderson et al., 2002), also display
impaired negative selection of autoreactive CD4þ T cells
(Liston et al., 2003).
Central deletion of TRP1-specific thymocytes likely
explains why AgþGILTþ /þTg mice do not develop sponta-
neous vitiligo. However, AgþGILT/Tg mice also failed to
develop vitiligo despite the presence of significant numbers
of TRP1-specific T cells in peripheral lymphoid organs
(Figure 2). Deficient Ag presentation in GILT-deficient
animals resulting in reduced ability to activate TRP1-specific
T cells is unlikely to fully account for the inability to develop
vitiligo for several reasons. RAG-expressing TRP1-specific
TCR Tg mice eventually develop spontaneous vitiligo in the
absence of GILT expression (Rausch et al., 2010). In addition,
TRP1-specific T cells from AgþGILT/Tg mice failed to
induce vitiligo following adoptive transfer into GILT-express-
ing hosts (Figure 3). Furthermore, some TRP1-specific T cells
from AgþGILT/Tg mice had an effector memory pheno-
type (CD62LCD44þ ; Figure 2c), demonstrating that TRP1-
specific T-cell activation can take place in the absence of
GILT. The inability of these T cells to induce vitiligo is likely
due to other tolerance mechanisms.
Although CD4þ TRP1-specific T cells escaped negative
selection in the absence of GILT, these cells were tolerant to
TRP1 and did not mediate vitiligo (Figure 3). Consistent with
this finding, TRP1-specific T cells from AgþGILT/Tg mice
had diminished cytokine production following Ag exposure
(Figure 4). The diminished activity of TRP1-specific T cells
from AgþGILT/Tg mice is partially due to increased TRP1-
specific Treg cells (Figure 5), as adoptive transfer of
CD4þCD25 T cells from AgþGILT/Tg mice induced mild
vitiligo in RAG/ recipients (Figure 6). This finding suggests
that GILT may modulate the development of Treg cells.
Intrathymic development of Treg cells involves presenta-
tion of self-peptides by thymic APCs. In a hemagglutinin
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Figure 3. CD4þ TRP1-specific T cells from GILT-deficient mice do not
induce vitiligo. (a) CD4þ TRP1-specific T cells were isolated from
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for vitiligo onset. Disease-free survival curves were compared by the log-rank
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an additional 7 weeks and did not develop vitiligo. Data represent three
pooled experiments. The group that received AgGILTþ /þTg T cells was
previously reported and is reproduced with permission (Rausch et al.,
2010; Copyright 2010; The American Association of Immunologists).
(b) Adoptive transfer of AgGILTþ /þTg T cells induced large patches of
depigmented fur and ocular damage. (c) Representative, unaffected
mouse. Ag, antigen; GILT, gamma-IFN-inducible lysosomal thiol reductase;
Tg, transgenic; TRP1, tyrosinase-related protein 1.
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(HA)-specific TCR Tg mouse model that expresses HA,
Treg cell frequency is increased in animals expressing a
high-affinity TCR, but the Treg cell compartment is un-
changed in animals expressing a lower affinity TCR,
suggesting that TCR affinity influences Treg cell development
(Jordan et al., 2001). Recent evidence also demonstrates that
the overall avidity of the interaction between self-reactive
thymocytes and their cognate self-peptide/MHC complexes
may direct T-cell fate (Hinterberger et al., 2010). Reduced
MHC class II expression on mTECs in OVA-specific TCR Tg
mice in which OVA expression is restricted to mTECs results
in diminished negative selection concomitant with an
expansion of OVA-specific Treg cells (Hinterberger et al.,
2010). In our model, although MHC class II expression is
unchanged on thymic APCs (unpublished data), the number
of TRP1 peptide/MHC complexes is likely reduced in the
absence of GILT. Therefore, the absence of GILT may
similarly reduce the avidity of TCR interaction with peptide/
MHC complexes and shift the fate of TRP1-specific thymo-
cytes from central deletion to Treg cell development.
Treg cells can also be induced in the periphery following
suboptimal Ag stimulation (Bruder et al., 2005; Kretschmer
et al., 2005). Peripheral Treg cell conversion is induced by
targeting low doses of HA peptide to DCs under conditions of
suboptimal costimulation in an HA-specific TCR Tg model
(Kretschmer et al., 2005). Similarly, targeting of HA peptide
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Figure 4. TRP1-specific T cells from GILT-deficient mice have diminished cytokine production after antigen exposure. (a) CD4þ lymph node cells from
AgGILTþ /þTg and AgþGILT/Tg mice were cocultured with bone marrow-derived dendritic cells and TRP1-expressing B16 melanoma (Mel) lysate,
TRP1-deficient squamous cell carcinoma (SCC) lysate, or TRP1 peptide. Some cells were cultured with anti-CD3 and anti-CD28 antibodies. IL-2 production
was measured by ELISA. Columns and bars represent means±SE of triplicate samples from one experiment. Data are representative of two experiments.
(b) CD4þ T cells from AgGILTþ /þTg and AgþGILT/Tg mice were adoptively transferred into RAG/ recipients. One week after transfer, lymph node
cells were collected from recipients and restimulated in vitro with PMA and ionomycin for 3 hours. IL-2, IFN-g, IL-10, and IL-17 expressions are shown
in CD4þ cells. Data are representative of two experiments. Ag, antigen; GILT, gamma-IFN-inducible lysosomal thiol reductase; Tg, transgenic;
TRP1, tyrosinase-related protein 1.
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to immature DCs in an HA-specific TCR Tg mouse model in
which HA is expressed in pancreatic b-cells led to an
increase in peripheral conversion of CD4þ T cells to Treg
cells and protected animals from developing diabetes (Bruder
et al., 2005). GILT-deficient APCs are capable of low-level
presentation of TRP1 (Rausch et al., 2010), and this
suboptimal presentation may induce TRP1-specific T cells
to undergo peripheral conversion to Treg cells.
Although Treg cell depletion restores the ability of TRP1-
specific T cells from AgþGILT/Tg mice to induce vitiligo
(Figure 6b), the severity of autoimmunity induced by these
cells is diminished in comparison with disease induced by
TRP1-specific T cells from AgGILTþ /þTg mice (Figure 3b).
This result suggests the contribution of other tolerance
mechanisms. Decreased numbers of TRP1-specific T cells
in AgþGILT/Tg mice compared with AgGILTþ /þTg mice
may reflect reduced proliferation or increased susceptibility
to peripheral deletion. Recent studies have characterized
specialized populations of lymph node stromal cells that
express tissue-restricted Ags and are capable of mediating
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AgþGILT/Tg mice, stained with antibodies to CD4, Vb14, CD25, and Foxp3, and analyzed by flow cytometry. Samples were gated on CD4þVb14þ cells.
(b) Percentage of TRP1-specific CD25þFoxp3þ cells from AgGILTþ /þTg and AgþGILT/Tg mice compared using an unpaired t-test (***Po0.001).
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pooled experiments with three mice per group. Ag, antigen; GILT, gamma-IFN-inducible lysosomal thiol reductase; Tg, transgenic;
TRP1, tyrosinase-related protein 1; Treg, regulatory T.
a b
100
80
D
is
ea
se
-fr
ee
 s
ur
viv
al
 (%
)
60
40
20
0
0 3 6 9 12 15
Weeks
Total CD4+
CD4+CD25–
Figure 6. Depletion of CD25þ Treg cells partially restores the ability of CD4þ TRP1-specific T cells from GILT-deficient mice to induce autoimmunity.
(a) Total CD4þ (n¼ 3) and CD4þCD25 (n¼ 7) TRP1-specific T cells were FACS-sorted from AgþGILT/Tg mice and adoptively transferred into RAG/
recipients by tail vein injection. Mice were followed up for vitiligo onset. Disease-free survival curves were compared by the log-rank test.
Data are from two pooled experiments. (b) Adoptive transfer of CD4þCD25 T cells induced the appearance of individual white hairs in recipient
mice (left). Mice that received total CD4þ T cells did not develop vitiligo (right). Ag, antigen; GILT, gamma-IFN-inducible lysosomal thiol reductase;
Tg, transgenic; TRP1, tyrosinase-related protein 1; Treg, regulatory T.
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peripheral deletion of autoreactive T cells (Lee et al., 2007;
Nichols et al., 2007; Gardner et al., 2008; Cohen et al.,
2010). These lymph node stromal cells may be involved in
maintenance of tolerance to TRP1.
Using a Tg mouse model, we have uncovered a role, to
our knowledge, previously unreported, for GILT in modulat-
ing tolerance to the melanocyte differentiation Ag TRP1.
Presentation of self-Ag in the thymus has an essential role in
the negative selection of autoreactive T cells and the
intrathymic generation of Treg cells. GILT facilitates the class
II-restricted processing of TRP1 (Rausch et al., 2010).
Enhanced presentation of TRP1 by the thymic APCs likely
modulates the development of TRP1-specific T cells. These
findings highlight a critical role for GILT in shaping the CD4þ
T-cell repertoire to tissue-restricted self-Ags capable of
mediating autoimmune disease and antitumor immunity.
MATERIALS AND METHODS
Mice
C57BL/6 (wild-type) and RAG1/ mice were obtained from Jackson
Laboratory (Bar Harbor, ME). GILT/ mice were kindly provided by
Dr Peter Cresswell (Maric et al., 2001). RAG1/ TRP1-specific TCR
Tg mice were generously provided by Dr Nicholas Restifo (Muranski
et al., 2008) and were backcrossed onto the GILT/ background.
Thymuses, spleens, and inguinal, axillary, and cervical lymph nodes
were isolated as described (Rausch et al., 2010). All animals were
housed in microisolator cages. These studies were approved by the
institutional review board.
Flow cytometry
Cells were stained with FITC, phycoerythrin, phycoerythrin-Cy7,
PerCP, or APC-conjugated mAbs against murine Vb14 (clone 14-2),
CD3 (145-2C11), CD4 (RM4-5), CD8 (53-6.7), CD25 (PC61.5),
CD49b (DX5), Foxp3 (FJK-16s), IL-2 (JES6-5H4), IL-10 (JES5-16E3),
IL-17A (eBio17B7), IFN-g (XMG1.2), and corresponding isotype
controls (BD Biosciences; eBioscience, San Diego, CA), as described
(Rausch et al., 2010). When indicated, dead-cell exclusion was
performed by staining with 7-AAD (10 mgml1; Sigma, St Louis,
MO). For intracellular cytokine staining, cells were stimulated
for 3 hours with 50 ngml1 phorbol 12-myristate 13-acetate (Sigma)
and 1 mgml1 ionomycin (Calbiochem, San Diego, CA) in the
presence of monensin (eBioscience); cells were fixed and perme-
abilized with IC Fixation/Permeabilization buffer (eBioscience).
Cell sorting was performed using a FACSAria-II cell sorter (BD
Biosciences).
Adoptive transfer
CD4þ TRP1-specific T cells were isolated from pooled lymph node
and spleen cells from AgGILTþ /þTg and AgþGILT/Tg mice
using the EasySep mouse CD4 positive selection kit (Stemcell
Technologies, Vancouver, Canada). CD4þ T-cell purity was
90–95%. Both groups in Figure 3 were conducted at the same time;
the control group was previously reported and is reproduced with
permission (Rausch et al., 2010; Copyright 2010; The American
Association of Immunologists). For Treg cell depletion, total CD4þ
and CD4þCD25 T cells were FACS-sorted from AgþGILT/Tg
pooled lymph node and spleen cells. The purity of sorted
CD4þCD25 T cells was 495%. In all cases, 2.5 105 CD4þ T
cells were injected intravenously into RAG/ mice. Mice were
visually inspected each week for the development of depigmented
fur and eye changes. The minimum criteria used to establish vitiligo
onset was either a 2-mm2 patch of white fur or a 1-cm2 patch with
scattered individual white hairs on the dorsum of the animal.
In vitro stimulation assay
CD4þ TRP1-specific T cells (1 105) were cocultured for 48 hours
with 5 105 wild-type bone marrow-derived DCs and B16.F10
melanoma lysate, murine TRP1109130 peptide NCGTCRPGWRG
AACNQKILTVR (10 mgml1), or PDV squamous cell carcinoma
(Fusenig et al., 1978) lysate, as described (Rausch et al., 2010). Some
T cells were stimulated with plate-bound anti-CD3e (145-2C11;
10 mgml1) and soluble anti-CD28 (37.51; 2mgml1). CD4þ T cells
were positively selected as above. The IL-2 concentration in culture
supernatants was determined by ELISA (BD Biosciences).
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